TickerFacts.

SELLAS Life Sciences Group, Inc. (SLS): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$3.0K
Year ended 2016-12-31
-78.1%
3-year compound annual growth
$286.0K2010-12-31: $172.0K2011-12-31: $163.0K2012-12-31: $49.0K2013-12-31: $286.0K2014-12-31: $86.0K2015-12-31: $107.0K2016-12-31: $3.0K$3.0K
2010-12-31 Depreciation & Amortization (USD) 2016-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2016-12-31$3.0K-97.2%2018-04-13, From 2016-01-01
2015-12-31$107.0K+24.4%2017-03-15, From 2015-01-01
2014-12-31$86.0K-69.9%2017-03-15, From 2014-01-01
2013-12-31$286.0Kn/c2016-04-15, From 2013-01-01
2012-12-31$49.0K-69.9%2015-03-05, From 2012-01-01
2011-12-31$163.0K-5.2%2014-03-17, From 2011-01-01
2010-12-31$172.0Kn/a2012-03-28, From 2010-01-01